BIOPHARM FORWARD ApS: Financial statements 2025
CVR: 32438784
Source: annual report 2025, Danish Business Authority
26/08/2024 – 25/08/2025
BIOPHARM FORWARD ApS (CVR 32438784) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. That is a decrease of 5.6% compared with the year before. Equity in the 2025 report amounted to DKK 1,741,315. The solvency ratio was 77.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 997,234
- Profit/Loss
- DKK 243,660
- Equity
- DKK 1,741,315
- Total Assets
- DKK 2,244,523
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 997 t. | 244 t. | 1.7 mio. | 1 |
| 2024 | - | 1.1 mio. | 385 t. | 1.6 mio. | 1 |
| 2023 | - | 550 t. | -107 t. | 1.4 mio. | 1 |
| 2022 | - | 584 t. | 156 t. | 1.6 mio. | 1 |
| 2021 | - | 928 t. | 1.5 mio. | 1.6 mio. | 1 |
Official annual report
How creditworthy is BIOPHARM FORWARD ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BIOPHARM FORWARD ApS has published its annual report for 2024. Gross profit came to DKK 1,056,751, and the net result was DKK 385,061.
About BIOPHARM FORWARD ApS
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.